References
- AronoffSRosenblattSBraithwaiteS2000Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study GroupDiabetes Care2316051111092281
- ColuccielloM2005Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitusArch Ophthalmol1231273516157815
- HerzMJohnsDReviriegoJ2003A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitusClin Ther2510749512809958
- LincoffAMWolskiKNichollsSJ2007Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trialsJAMA2981180817848652
- MudaliarSChangARHenryRR2003Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implicationsEndocr Pract94061614583425
- NiemeyerNVJanneyLM2002Thiazolidinedione-induced edemaPharmacotherapy22924912126225
- PerkovichBTMeyersSM1988Systemic factors affecting diabetic macular edemaAm J Ophthalmol10521123277439
- RyanEHJrHanDPRamsayRC2006Diabetic macular edema associated with glitazone useRetina265627016770264
- TokuyamaTIkedaTSatoK2000Effects of haemodialysis on diabetic macular leakageBr J Ophthalmol84139740011090481